Capital Impact Advisors, LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 359 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital Impact Advisors, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$3,602,000
+19.2%
63,7070.0%0.88%
-1.3%
Q3 2020$3,023,000
-19.5%
63,7070.0%0.90%
-28.5%
Q2 2020$3,756,000
+9.9%
63,707
-11.8%
1.25%
-12.6%
Q1 2020$3,417,000
-16.1%
72,267
+7.2%
1.44%
+0.1%
Q4 2019$4,074,000
+10.5%
67,433
+8.0%
1.43%
+2.1%
Q3 2019$3,688,000
+138.9%
62,434
+161.6%
1.40%
+148.2%
Q2 2019$1,544,000
+25.9%
23,8660.0%0.57%
+4.2%
Q1 2019$1,226,0000.0%23,8660.0%0.54%
+3.6%
Q4 2018$1,226,000
-0.7%
23,8660.0%0.52%
+23.6%
Q3 2018$1,235,000
+23.3%
23,8660.0%0.42%
+14.3%
Q2 2018$1,002,000
-4.8%
23,8660.0%0.37%
-14.3%
Q1 2018$1,052,00023,8660.43%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders